Federal Register / Vol. 75, No. 195 / Friday, October 8, 2010 / Notices 62403 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: September 30, 2010. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2010–25053 Filed 10–7–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer on (240) 276– 

1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and 

(d) ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: 2011–2014 National 

Survey on Drug Use and Health: 

Methodological Field Tests (OMB No. 

0930–0290–Revision) 

The National Survey on Drug Use and 

Health (NSDUH) is a survey of the 

civilian, non-institutionalized 

population of the United States 12 years 

old and older. The data are used to 

determine the prevalence of use of 

tobacco products, alcohol, illicit 

substances, and illicit use of 

prescription drugs. The results are used 

by SAMHSA, ONDCP, Federal 

government agencies, and other 

organizations and researchers to 

establish policy, direct program 

activities, and better allocate resources. 

In March 2008, SAMHSA received a 

three-year renewal of its generic 

clearance for methodological field tests. 

This will be a request for another 

renewal of the generic approval to 

continue methodological tests over the 

next three years, with conditions similar 

to the previous clearance. These 

methodological tests will continue to be 

designed to examine the feasibility, 

quality, and efficiency of new 

procedures or revisions to existing 

survey protocol. Specifically, the tests 

will measure the reliability and validity 

of certain questionnaire sections and 

items through multiple measurements 

on a set of respondents; assess new 

methods for gaining cooperation and 

participation of respondents with the 

goal of increasing response and 

decreasing potential bias in the survey 

estimates; and assess the impact of new 

sampling techniques and technologies 

on respondent behavior and reporting. 

Research will involve focus groups, 

cognitive laboratory testing, field tests, 

and customer surveys. 

The next wave of methodological tests 

will continue to examine ways to 

increase data quality, lower operating 

costs, and gain a better understanding of 

sources and effects of nonsampling error 

on the NSDUH estimates. Particular 

attention will be given to minimizing 

the impact of design changes so that 

survey data continue to remain 

comparable over time. If these tests 

provide successful results, current 

procedures or data collection 

instruments may be revised. 

The number of respondents to be 

included in each field test will vary, 

depending on the nature of the subject 

being tested and the target population. 

However, the total estimated response 

burden is 8,251 hours. The exact 

number of subjects and burden hours for 

each test are unknown at this time, but 

will be clearly outlined in each 

individual submission. The table below, 

however, describes the anticipated 

burden for each of the major testing 

activities for which generic approval is 

being tested. 

ESTIMATED BURDEN FOR NSDUH METHODOLOGICAL FIELD TESTS

Activity Number of 

respondents 

Responses 

per 

respondent 

Total number 

of responses 

Average 

burden per 

response 

(hrs.) 

Total burden 

(hrs.) 

a. Focus Groups .............................................................. 270 1 270 2 .0 540 

b. Cognitive laboratory testing ......................................... 200 1 200 1 .0 200 

c. Field Tests ................................................................... 6,600 1 6,600 1 .0 6,600 

d. Customer Satisfaction Surveys ................................... 300 1 300 0 .25 75 

Household screening for c ............................................... 8,910 1 8,910 0 .083 740 

Screening Verification for c .............................................. 445 1 445 0 .067 30 

Interview Verification for c ............................................... 990 1 990 0 .067 66 

Total .......................................................................... 17,715 ........................ 17,715 .......................... 8,251 

Annual Average (Total divided by 3 years) ....... 5,905 ........................ 5,905 .......................... 2,750 


erowe on DSK5CLS3C1PROD with NOTICES
62404 Federal Register / Vol. 75, No. 195 / Friday, October 8, 2010 / Notices 

Send comments to Summer King, 

SAMHSA Reports Clearance Officer, 

Room 8–1099, One Choke Cherry Road, 

Rockville, MD 20857 and e-mail a copy 

to summer.king@samhsa.hhs.gov. 

Written comments should be received 

within 60 days of this notice. 

Dated: September 30, 2010. 

Elaine Parry, 

Director, Office of Management, Technology 

and Operations. 

[FR Doc. 2010–25439 Filed 10–7–10; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Financial Institution Data 

Match. 

OMB No.: 0970–0196. 

Description: Section 466(a)(17) of the 

Social Security Act (the Act) requires 

States to establish procedures under 

which the State Child Support 

Enforcement IV–D agencies shall enter 

into agreements with financial 

institutions doing business in States for 

the purpose of securing information 

leading to the enforcement of child 

support orders. Under 452(l) and 

466(a)(17)(A)(i) of the Act, the Secretary 

may aid State agencies conducting data 

matches with financial institutions 

doing business in multiple States by 

centrally matching through the Federal 

Parent Locator Service. 

Respondents: Financial institutions 

doing business in two or more States. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Financial Data Match Result File .................................................................. 259 4 0.33 341 .88 

Election Form ................................................................................................. 122 1 0.50 61 

Estimated Total Annual Burden Hours ................................................... ........................ ........................ ........................ 402 .88 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–7285, 

E-mail: 

OIRA_SUBMISSION@OMB.EOP.GOV 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: October 5, 2010. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2010–25414 Filed 10–7–10; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0493] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Additional Criteria 

and Procedures for Classifying Overthe-Counter Drugs as Generally 

Recognized as Safe and Effective and 

Not Misbranded 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the additional criteria and procedures 

for classifying over-the-counter (OTC) 

drugs as generally recognized as safe 

and effective and not misbranded. 

DATES: Submit either electronic or 

written comments on the collection of 

information by December 7, 2010. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth Berbakos, Office of 

Information Management, Food and 

Drug Administration, 1350 Piccard Dr., 

PI50–400B, Rockville, MD 20850, 301– 

796–3792, 

Elizabeth.Berbakos@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined in 

44 U.S.C. 3502(3) and 5 CFR 1320.3(c) 

and includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to provide a 60-day notice in the 

Federal Register concerning each 

proposed collection of information 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 


erowe on DSK5CLS3C1PROD with NOTICES